TearClear Announces Successful Completion of Pre-IND Meeting With the FDA for a Preservative Free Multi-Dose Delivery of Latanoprost for the Treatment of Glaucoma
UF startup and UF Innovate | Sid Martin Biotech resident client TearClear, an emerging ophthalmic pharmaceutical company, announced successful completion of pre-IND (Investigational New Drug) meeting with the U.S. Food and Drug Administration (FDA) regarding the development plan for the preservative free multi-dose delivery of a proprietary Latanoprost formulation, including the clinical study design for the registration study.
UF Researcher Finds a Way to Mitigate Acute Respiratory Distress Syndrome (ARDS), a Complication of Coronavirus Infection
Why would a doctor specializing in gastrointestinal disorders be interested in therapy for COVID-19, a primarily pulmonary disease? The answer lies in a seemingly convoluted link between the gastrointestinal tract and the lungs: water.
University of Florida Citrus Faculty Highly Sought After as Research Partners in Fight Against Greening
University of Florida citrus researchers continue to be sought out as partners in ground-breaking research projects to fight Huanglongbing, also known as citrus greening disease.
Zare’s $1.2 Million Award Brings Machine Learning to Plant Root Science
A team of researchers from ECE Florida and IFAS has received a $1.2M grant from the United States Department of Agriculture (USDA) that combines machine learning, hyperspectral cameras, and minirhizotron tubes to study root systems of plants over time.
New Study Tests Effectiveness of High-Intensity Exercise in Slowing Parkinson’s Symptoms
The University of Florida is collaborating on a new Phase 3 multisite clinical trial that will test the effectiveness of high-intensity and moderate-intensity treadmill exercise in slowing the progression of Parkinson’s disease symptoms.
Seven UF Researchers Named 2020 AAAS Fellows
Seven University of Florida researchers have been named Fellows of the American Association for the Advancement of Science, the world’s largest general scientific society.
Huvepharma Introduces New Necrotic Enteritis Vaccine Developed by Curtiss Healthcare, Inc.
Huvepharma, Inc., a pharmaceutical company with a focus on developing, manufacturing and marketing human and animal health products, has introduced AVERT NE, an innovative new vaccine to help control necrotic enteritis (NE) due to Clostridium perfringens Type A.
UF/IFAS Researchers Help Wineries Capitalize on Carbonation Craving
University of Florida researchers are helping wineries make their product bubbly to meet taste trends and expand their business.
UF Health Researcher Helps Show Hormone Can Reverse Inflammation From Fatty Liver Disease
Pushed by the obesity epidemic, a rising number of Americans are being diagnosed with nonalcoholic fatty liver disease, a condition that can lead to liver inflammation and cirrhosis. It is now the leading cause of liver transplantation in the United States.
Ology Bioservices Awarded $37 Million for Advanced Development of Anti-COVID-19 Monoclonal Antibody Cocktail
UF startup and UF Innovate | Sid Martin Biotech alum Ology Bioservices Inc., a biologics contract development and manufacturing organization (CDMO), announced that the Department of Defense (DOD) has awarded the company with an agreement valued at $37 million.
